Stockholders’ Equity - Stock Subject to Vesting and Earn-out Share Liability (Details) - USD ($) $ in Millions	1 Months Ended		3 Months Ended	6 Months Ended
	Jul. 31, 2021	Jun. 30, 2021	Jun. 30, 2024	Jun. 30, 2024
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock acquisition-related earn-out consideration (in shares)			119,344	119,344
Restricted Stock | Honest Health Limited
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, amount			$ 1.3	$ 1.3
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)				11 months 12 days
Restricted Stock | Employee | Honest Health Limited
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)		4 years
Restricted Stock | Employee | Honest Health Limited | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		447,553
Aggregate grant date fair value		$ 5.5
Restricted Stock | Employee | Apostrophe
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Restricted Stock | Employee | Apostrophe | Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	2,332,557
Aggregate grant date fair value	$ 24.2
Restricted Stock | Employee | Share-based Payment Arrangement, Tranche One | Honest Health Limited
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)		1 year
Awards vesting rights, percentage		25.00%
Restricted Stock | Employee | Share-based Payment Arrangement, Tranche One | Apostrophe
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	6 months
Awards vesting rights, percentage	17.00%